The current landscape of the FDA approved companion diagnostics

The current landscape of the FDA approved companion diagnostics

Predictive biomarker is an important element in the realization of precision medicine and with the introduction of the drug-diagnostic codevelopment model, the number of regulatory approved companion diagnostics (CDx) have steadily increased. This short perspective is based on an analysis of the FDA...

Full description

Bibliographic Details
Main Author: Jan Trøst Jørgensen
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Translational Oncology
Subjects:
Companion diagnostics
Biomarkers
Premarket application
Laboratory developed test
Precision medicine
Personalized medicine
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523321000553

Internet

http://www.sciencedirect.com/science/article/pii/S1936523321000553

Similar Items